Williams Lewis T 4
4 · Neoleukin Therapeutics, Inc. · Filed May 7, 2020
Insider Transaction Report
Form 4
Williams Lewis T
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-05-05+25,000→ 25,000 totalExercise: $12.84Exp: 2030-05-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the total shares monthly beginning June 5, 2020 until the option is fully vested on May 5, 2021, subject to the Reporting Person's provision of service to the Issuer on each vesting date.